Dr. Kaja Simon

Dr. Kaja Simon

Ph.D. | Assistant Professor and Associate Director for Preclinical Research

University of Missouri - Kansas City, School of Medicine
Kansas City, United States of America, 64108

plus Speciality

NEUROSCIENCES

Biography:

Dr. Kaja is Assistant Professor of Ophthalmology and the Associate Director Preclinical Research of the Vision Research Center at the University of Missouri - Kansas City, School of Medicine. Dr. Kaja’s active research laboratory is interested in human neurological diseases and visual disorders, including migraine, cerebellar ataxia, stroke and epilepsy. Using a broad experimental approach, ranging from molecular biology to electrophysiology and imaging, the lab is working towards the identification of novel targets for pharmaceutical intervention for these often devastating diseases. Current funded research projects in the lab include the study of the synaptic basis for visual impairments during migraine, as well as synaptic transmission defects in migraine and cerebellar ataxia in general. Another focus is on the development of novel neuroprotective strategies following oxidative stress and ischemia. Dr. Kaja graduated from Durham University top of his class with a B.Sc. degree in Molecular Biology and Biochemistry. For his undergraduate work, he was awarded the British Neuroscience Association Undergraduate Award and the Boulter Prize in Molecular Biology. Continuing his line of research, Dr. Kaja completed his Ph.D. in Medicine, subspecialty Neuroscience, Neurology and Human Genetics at the Leiden University Medical Center, where contributed to the development and characterization of the most clincally relevant preclinical models for migraine. Dr. Kaja received his postdoctoral training in the pioneering laboratory of Prof. Terrance Snutch at the University of British Columbia, funded by the European Molecular Biology Organization and the Michael Smith Foundation for Health Research. In 2009, Dr. Kaja established his laboratory at UMKC where he maintains an active, funded research program. Dr. Kaja regularly consults to the pharmaceutical industry in his area of expertise (especially ataxia and migraine), and has delivered over 25 invited lectures at conferences and institutes both nationally and internationally.

Academic positions:

Assistant Professor, UMKC School of Medicine, Department of Ophthalmology | Associate Director Preclinical Research, Vision Research Center | Adjunct Doctoral Faculty, UMKC School of Medicine

Research interests:

Dr. Kaja’s lab is interested in human neurological diseases and visual disorders, including migraine, cerebellar ataxia, stroke and epilepsy. Using a broad experimental approach, ranging from molecular biology to electrophysiology and imaging, the lab is working towards the identification of novel targets for pharmaceutical intervention for these often devastating diseases. Current funded research projects in the lab include the study of the synaptic basis for visual impairments during migraine, as well as synaptic transmission defects in migraine and cerebellar ataxia in general. Another focus is on the development of novel neuroprotective strategies following oxidative stress and ischemia.

What I think of the idea behind WebmedCentral and WebmedCentral plus:

Scientific publishing has faced significant problems in recent years, mostly resulting from the ease of dissemination of information through the internet. Increased access to a wider variety of sources for research results requires a fairer and more transparent evaluation and review process. WebmedCentral provides a unique strategy of open access, and the one of its kind combination of post- and pre-publication review through WedmedCentral and WebmedCentralPlus, respectively.